S versus-host disease (GVHD) across both major (H-2) and minor (non-H-2) histocompatibility barriers is mediated by donor T lymphocytes and can be prevented by removal of T lymphocytes from the spleen/marrow cell inoculum.'-4 In man, similarly, the incidence of acute GVHD can be reduced substantially with T-cell depletion from the donor marrow?-' However, this approach has also been associated with an increased incidence of graft failure and recurrence of the underlying Clearly, alternative approaches are needed.
We have recently shown that treatment of human bone marrow with UVB light selectively inhibits lymphocyte function while preserving hemopoietic colony formation.'" Furthermore, we have shown in a canine model of autologous marrow transplantation that UVB/C treatment of lymphocytes from DLA-incompatible donors transfused posttransplant prevents the development of GVHD." In the current study, we investigated in a murine model the effects of UVB irradiation on lymphocyte and hematopoietic precursor functions and determined whether UVB irradiation of donor cells could prevent GVHD while allowing for the development of specific tolerance and complete hemopoietic reconstitution in recipients prepared with lethal doses of total body gamma irradiation (TBI).
MATERIALS AND METHODS
C57B1/6J (H-2'), DBAI2J (H-2d), BALB/cJ (H-2d), BALB.k (H-2'), C3H/HeJ (H-2'), and C57B1/6J x DBAI2J (B6D2) F, mice were purchased from Jackson Laboratories (Bar Harbor, ME). Mice were 8 to 12 weeks old, and donors and recipients were age-and sex-matched within each experiment.
The response of spleen cells to allogeneic stimulation in MLC was examined as described.'* Briefly, responder cells (5 X 1OS/well) were cocultured with allogeneic stimulator cells (1 X lO'/well, gamma-irradiated with 3,000 cGy immediately before culture) in 0.2" volumes in modified Click's medium in flat-bottom microtiter plates (Costar, Cambridge, MA). After incubation for 5 days at 37°C in a 7% CO, humidified air atmosphere, 1 $ 3 'H-thymidine per well was added Mice.
Mixed lymphocyte cultures (MLC).
survived without GVHD. At 2.5 and 5.0 mJ/cm2, mice showed signs of GVHD, beginning at day 30, and 100% and 80%. respectively, eventually developed chronic GVHD. At 7.5 mJIcm', mice had weight loss, from which 60% recovered and survived without GVHD, while 40% died with GVHD. At 15 mJ/cm2, some recipients died from graft failure, while some survived without GVHD. All surviving mice were complete donor-type chimeras. Spleen size and cellularity and in vitro lymphocyte responses correlated inversely with the development of GVHD. Mice without GVHD showed specific tolerance to skin grafts from the second parent strain, while animals with GVHD rejected their skin grafts. Thus, in a murine model UVB irradiation of transplanted hemopoietic stem cells allows for hemopoietic reconstitution and prevents GVHD. 0 1991 by The American Society of Hematology. and plates were incubated for another 18 hours. Cells were harvested and uptake counted by standard methods.
Spleen cells at 2.5 X lo6 cells/mL were cultured as described for MLC. Concanavalin A (Con A, Sigma, St Louis, MO) was added at 1 pg/mL or 0.1 kg/mL; phytohemagglutinin (PHA, Difco, Detroit, MI) was added at 0.2% or 0.02%. After 72 hours' incubation, 'H-thymidine was added to cultures, and after 18 hours, cells were harvested and 'H-thymidine uptake counted as described for MLCs above.
Recipient mice were exposed to 1,000 cGy of TBI at an exposure rate of 70 cGy/min from a '"Cs source (Best Industries, Springfield, VA). This dose of irradiation has previously been shown to result in death in 95% of exposed B6D2 F, mice within 11 days13 (unpublished data).
Recipient mice received 1,000 cGy of TBI and spleen cells (5 X lo6 cells/mouse), either unexposed or irradiated with 0.5 to 10 mJ/cmZ of UVB, injected intravenously. On day 8, mice were killed, spleens were fixed in Bouin's solution, and surface colonies were ~0 u n t e d . l~ Cells were exposed to UV light as described."." Briefly, a UVB lamp (Spectroline XX-15B, Spectronics, Westbury, NY) with maximum emission (85%) at 302 nm, and a spectrum of 280 to 320 nm was used for UVB irradiation. Cells were resuspended in phosphate-buffered saline (PBS) at 30 to 40 x 106/mL and aliquoted into 60-mm Petri dishes (Falcon, Oxnard, Mitogen responses.
TBI.

Colonylfoming unit-spleen (CFU-S).
UV irradiation of cells.
CA) to a maximum depth of 1.5 mm; the open dishes were placed on wet ice and exposed to UV light. Different doses were achieved by exposing cells for different lengths of time at predetermined distances from the UV lamp. Exposure was monitored using a Spectroline DM-300x UV meter measuring in the spectral range from 280 to 320 nm. After irradiation, cells were gently scraped from the dishes, washed, and resuspended in appropriate medium for use.
An ex vivo GVH assay, as described by Sharkis et a1,I6 was used as an early assessment of UV effects. C57B1/6J spleen cells were prepared and UVB-treated as described above and injected into lethally irradiated C57B1/6J or B6D2 F, recipients (12.5 X lo6 cells/mouse). On day 5, recipients were killed and spleen cells (3 X lo5 cells/well) were cultured in 96-well flat-bottom culture plates in the presence of 'H-thymidine for 4 hours to determine spontaneous in vitro proliferation of these cells following in vivo exposure to syngeneic or allogeneic hosts. Donor mice were killed and marrow cells were flushed from the tibiae and femora with Hank's enriched medium (HEM) containing 10% fetal calf serum (FCS) and processed as described." After appropriate in vitro manipulations, cells were washed three times and the indicated numbers of viable nucleated cells (bone marrow alone or bone marrow plus spleen cells) were injected intravenously into recipients prepared with 1,000 cGy TBI. Mice were given 0.2% tetracycline hydrochloride in their drinking water and housed in sterile cages on a laminar flow rack beginning 1 week before irradiation and maintained on this regimen throughout the experiment. Mice were examined daily for signs of GVHD (weight loss, hunched posture, ruffled fur, alopecia). In all experiments and at each dose level five animals were entered per group. Chimerism was determined as described." Briefly, lo6 spleen cells, suspended in 0.1 mL HEM, were mixed with 0.1 mL monoclonal antibody supernatant and 0.05 mL rabbit complement (Accurate Scientific and Chemical, Westbury, NY). After incubation at 37°C for 1 hour, cells were washed and resuspended in 0.2% trypan blue for viability determination using light microscopy. Monoclonal antibodies 28-8-63 (anti-H-2K"Dh, murine IgG2a) and 34-2-12s (anti-H-2@, murine IgG2a) were generous gifts from Dr David Sachs, National Cancer Institute.
Skin grafts from the parent strain that had not been used as marrow/spleen cell donor and from a third-party strain were performed by standard techniques. Skin grafts were inspected daily for viability.
Survival and survival free of clinical GVHD in mice transplanted with hemopoietic cells exposed to different doses of UVB light were compared using a log rank trend test as described by Kalbfleisch and Prentice.18
Ex vivo assay of GVH reaction.
Marrow transplantation and care.
Determination of chimerism.
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RESULTS
In vitro lymphocyte proliferation after UVB irradiation. As in other species, responses of murine spleen cells to gamma-irradiated stimulator cells in MLC were more sensitive to UVB light than were responses to mitogen~'~.'': while MLC responses were reduced to less than 1% of control after 5 mJ/cm2, 7.5 to 10 mJ/cm2 were required to eliminate Con A-and PHA-induced proliferation. Of note was the observation that the response to Con A at optimal concentration was increased relative to controls at low doses of UVB.
Following injection of 5 x 106 spleen cells into lethally irradiated recipients, 20
Effect of UVB irradiation on CFU-S. to 25 colonies per mouse were identified on day 8 (Fig 1) . This number was not altered by exposure of spleen cells to 0.5 to 7.5 mJ/cm2 of UVB before injection; at doses of greater than or equal to 10 mJ/cm2, CFU-S decreased to less than 10% of control. Thus, there was a dose range at which lymphocytes capable of lectin and alloantigen responses were eliminated, while colony-forming cells survived.
-
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In an attempt to determine whether in vivo GVH reactivity was as sensitive to UVB light as was in vitro proliferation in MLC, B6 spleen cells were UVB-irradiated and injected into gammairradiated (1,000 cGy) B6 or B6D2 F, recipients; on day 5, spleens were removed and assayed in vitro for proliferation (Table 1) . Untreated B6 spleen cells injected into F, Ex vivo assay of GVH reaction. Lethally irradiated (1,000 cGy) B6 or B6D2 F, recipients were injected with untreated or UVB-exposed B6 spleen cells. On day 5, spleen cells from these animals were harvested to assay for spontaneous in vitro proliferation as determined by 'H-thymidine uptake. Values are mean cpms of three experiments 2SEM.
For personal use only. on July 10, 2017. by guest www.bloodjournal.org From PREVENTION OF GVHD BY UVB IRRADIATION 3319 recipients proliferated more vigorously than the same cells injected into syngeneic B6 recipients, presumably due to stimulation by recipient antigens in vivo. Lymphocytes from recipients given spleen cells exposed to 5 to 10 mJ/cm2 of UVB showed a modest decrease of proliferation in F, recipients. Exposure to 12.5 mJ/cm2 reduced proliferative response to less than 25%, and 15 mJ/cm2 to less than 5% of control.
Lethally irradiated B6D2 F, mice were injected with 1.0 to 10.0 X lo6 of C57B1/6 spleen cells (to induce GVHD) and 5 X lo6 C57B1/6 unmanipulated bone marrow cells; with 5 x lo6 spleen cells, all mice died with GVHD (median, 45 days). With 10 x lo6 spleen cells, deaths occurred earlier (median, 23 days) and this cell dose was used subsequently to examine UVB effects on GVHD.
Prevention of G W D by UVB irradiation of spleen cells. Lethally irradiated B6D2 F, recipients were given untreated C57B1/6 bone marrow cells and 10 X lo6 untreated or UVB exposed C57B1/6 spleen cells. Ail mice given unmanipulated spleen cells developed GVHD and 80% died before day 40. All mice injected with spleen cells that had been exposed to UVB at doses of 5 to 15 mJ/cm* survived more than 250 days. At 5 and 7.5 mJ/cm2 of UVB, beginning at day 30, mice experienced a transient weight loss of 18% to 25%. However, all mice had recovered completely by day 70. Studies on day 120 showed all mice to be complete donor hemopoietic chimeras. Chimera cells were unresponsive to DBA/2 (parental) stimulators, but responded vigorously to third-party (C3H) stimulators (data not shown).
Results are summarized in Fig 2. Ail radiation controls (not given marrow) died within 16 days, while all recipients of shamtreated syngeneic bone marrow survived beyond 250 days. Similarly, all recipients of syngeneic bone marrow treated with 2.5 to 10 mJ/cm2 survived with complete hemopoietic reconstitution. At 12.5 mJ/cmZ and 15 mJ/cm2, 20% and 80%, respectively, died. Spleen cells from long-term survivors responded normally to allogeneic (BALB.k, H-2k) stimulator cells (Table 2 ) and to mitogens (data not shown),
Effect of UVB on hemopoietic reconstitution. indicating that UVB treatment of bone marrow had not impaired T-cell recovery.
Hemopoietic reconstitution and prevention of G W D with UI'B-treated marrow and spleen cells.
Results are summarized in Figs 3 and 4. All mice given untreated cells developed GVHD at a median of 30 days and died (median survival, 80 days). Mice transplanted with cells exposed to 2.5 mJ/cmz developed GVHD at a median of 100 days. The appearance of GVHD was chronic in nature, and 60% of animals survived more than 200 days. As the dose of UVB increased to 5 and 7.5 mJ/cm2, the incidence of clinically apparent GVHD decreased, although survival was not different from that seen with 2.5 mJ/cm2. At 10 and 12.5 mJ/cm2, none of the mice developed GVHD and all survived more than 200 days. At 15 mJ/cm2, none of the mice developed GVHD, but only one animal survived more than 200 days. Thus, the probability of developing clinically apparent GVHD significantly decreased (P = .OOl) and the probability of survival increased ( P = .003) with increasing doses of UVB.
As illustrated in Table 3 , examination of spleen cells on day 200 showed that at all dose levels recipients were complete chimeras, suggesting that even at 15 mJ/cm2 of For personal use only. on July 10, 2017. by guest www.bloodjournal.org From UVB, some hemopoietic stem cells capable of reconstituting the recipient had survived.
Spleens of recipients of cells exposed to 2.5, 5.0, or 7.5 mJ/cm* of UVB were small and cell numbers reduced to 10% to 15% of normal; spleens were larger and cell numbers higher (50% to 80% of normal) at 10 to 15 mJ/cm2.
In vitro proliferative capacity of chimera spleen cells on day 210 posttransplant is summarized in Table 4 . Responses to PHA and Con A were comparable or superior to those observed with donor strain or normal recipient strain cells. Also, spleen cells from chimeras showed responses to third-party (CBA/J) cells similar or superior to those of control cells. Chimera cells showed some proliferation in response to DBA/2 (the nontransplant donor parent strain) cells at UVB doses of 2.5 to 7.5 mJ/cmz, suggesting that tolerance had not been achieved. At UVB doses of 10 and 15 mJ/cm*, spleen cells showed specific nonresponsiveness to DBA/2 cells; some proliferation was observed at 12.5 mJ/cm2.
To further determine the establishment of tolerance and its specificity, skin grafts from DBA/2 and CBA/J mice were placed on chimeras on day 215 or day 240. Two mice transplanted with cells exposed to 2.5 mJ/cm2 of UVB rejected both DBA/2 and CBA/J skin grafts on day 7. In contrast, three recipients of cells exposed to 10.0 or 12.5 mJ/cm2 of UVB rejected CBA/J skin grafts on day 7, but maintained healthy DBA/2 grafts for more than 115 and 140 days, respectively.
DISCUSSION
The present study shows that UVB irradiation of lymphohemopoietic cells prevents GVHD in a murine parent into F, model. The UVB doses used allowed for sustained hemopoietic reconstitution, as well as for the development of specific tolerance as determined by lymphoproliferative responses in vitro and skin graft survival in vivo.
We reported previously that UVB irradiation of human bone marrow cells preferentially eliminates T lymphocytes or inhibits T-lymphocyte function at UVB doses which preserve in vitro hemopoietic colony formation.'" In addition, we observed in a canine model that UVB irradiation of histoincompatible leukocytes prevents transfusion-induced GVHD in immunosuppressed recipients." Results obtained in the present model follow those findings and show that UVB irradiation not only spares committed hemopoietic precursors in vitro, but also hemopoietic stem cells in a marrow transplant model in vivo. However, in vitro/in vivo correlations must be interpreted cautiously. UVB doses of 5 or 7.5 mJ/cm2, while suppressing alloresponsiveness in vitro, did not completely prevent the development of GVHD in vivo. At least 10 mJ/cm2, a dose that significantly reduced CFU-S in a syngeneic model, was required to completely suppress GVHD, and 12.5 mJ/cm2 were necessary to prevent in vivo alloactivation as determined by an ex vivo assay of GVH reactivity." These data indicate that in vivo allointeractions of cells result in stronger activation signals than those provided in vitro or in syngeneic models, and suggest that additional mechanisms, not tested in the available in vitro assays, are operational in the in vivo abrogation of proliferation of alloactivated donor cells. Similarly, inactivation of spleen cells as determined by CFU-S or in vitro proliferation does not necessarily affect the capacity of hemopoietic stem cells to repopulate a transplant recipient.
Of note was an increase in Con A responses at low dose (2.5 mJ/cm2) of UVB. We had noted previously that the plating efficiency of CFU-granulocyte-monocyte (CFU-GM) from human marrow also increased at low-dose UVB.'" Similarly, there was an increase in MLC stimulating ability of allogeneic human cells early after low-dose UVB in contrast to a decline at higher doses.I5 The mechanism is unclear. Kaba et aIz0 and Daynes et aIz1 have suggested that UV irradiation induces neoantigen expression on human cells. We have observed induction of expression of some oncogenes (eg, c-myc) by UVB light." Conceivably, a
For personal use only. on July 10, 2017. by guest www.bloodjournal.org From similar UVB-induced change in cellular activation is responsible for increased lectin responsiveness.
Pamphilon et a1 observed that UVB irradiation of murine marrow cells delays hemopoietic reconstit~tion.~~ Although we did not formally investigate the kinetics of hemopoietic recovery, marrow cellularity was normal in mice autopsied 120 to 210 days posttransplant. The small spleen size seen in some groups of mice was presumably related to GVHD, since the same animals also had experienced clinically overt GVHD or transient weight loss. Although acute GVHD typically results in an increase in spleen size,24 splenic and generalized lymphoid atrophy usually occur later.25 Functional asplenia has also been described in association with chronic GVHD in humans. 26 All recipients studied were complete allogeneic (donortype) chimeras. Even after 15 mJ/cm2 of UVB, those animals that did not die from early marrow aplasia eventually showed donor-derived hemopoiesis. This is in contrast to the observation by Pamphilon et al, who found a high incidence of mixed donor/host chimerism or reconstitution in host cells in both parent into F,, and in completely allogeneic chimera^.'^ This could be related to the mouse strain used (BALB/c v C57 BL/6 donor), the UVB wavelength (mean of 310 nm v 302 nm in the present study), or the dose of UVB actually delivered to hemopoietic cells. We have shown previously that the conditions under which cells are UVB exposed, the contamination with erythrocytes, and additional factors strongly influence the dose fraction that reaches the cells.27
Regardless of the doses delivered, these data are in agreement with those in the murine model described by Pamphilon et aIz3 and in a rat model reported by Chabot et aIz8 and Pepino et aLZ9 In addition, Ullrich has shown that photosensitization of mice with psoralen and UVA irradiation of their marrow also prevents GVHD in histoincompatible murine recipients3' Taken together, these studies provide convincing evidence for the ability of UV light to prevent GVHD and establish tolerance.
The mechanism remains to be defined. Several experimental approaches suggest that UVB induces tolerance by changing allogeneic signals to tolerogenic signal^,^' presumably by eliminating a costimulatory factor. In addition, we and others have shown that UVB modifies class I1 antigen expression on the cell ~u r f a c e~* .~~ and alters calcium homeo~tasis.'~ It is also likely that UVB exposure results in the death of certain, especially activated cell populations, via a p o p t o s i~.~~ Data by Gruner et a1 suggest that at longer wavelengths (UVA), exposure in conjunction with photosensitizers results in isomerization of trans-into cis-urocanic acid, which may have immunosuppressive effects. 35 Long-term effects of UVB light in this setting remain to be determined. It will be of interest to perform sequential transplants into secondary recipients, not only to determine whether the state of tolerance can be transferred, but also to investigate whether UVB irradiation results in mutations manifest in clonal evolution that can lead to the development of lymphohemopoietic malignancies.
In conclusion, we have shown that UVB manipulation of murine spleen and marrow cells at low doses results in chronic GVHD. At higher doses, tolerated by hemopoietic cells, specific tolerance is induced, while full immunocompetence is established. For personal use only. on July 10, 2017. by guest www.bloodjournal.org From
